Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), closed its United States-only public offering raising approximately $2.25 million. The offering consisted...
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,... The post Glancy Prongay...
Renowned billionaire investor Steve Cohen has purchased almost 19 million shares of Cybin. The post Billionaire Investor Steve Cohen Buys 19 million Shares...
Psychedelics firm Mydecine Innovations Group Inc. (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA), which is still in the pre-revenue stage, announced a plan to offer...
Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed. The post News...
A new study published in the “ACS Pharmacology & Translational Science” journal has revealed that psychedelics such as psilocybin may combat stress...
Beckley Waves raises $3.3 million, capital to be used for investing in startups focused on infrastructure and services for psychedelic therapies. The post...
Post-traumatic stress Disorder (PTSD) is a debilitating mental health condition that affects millions of people worldwide. It affects 5% of the US population,...
MAPS is preparing to submit a formal new drug application to the FDA by end of year The post MAPS Inches Closer to Federal New Drug...
The global inflation surge and monetary policy tightening by major central banks have all contributed to the market volatility this year. Despite that,...